Lactiga™ is an award-winning, venture-backed biotechnology company developing innovative mucosal antibody therapies to advance the future of immunoscience. We are unlocking the full therapeutic value of human milk to create the world’s first platform for secretory IgA antibodies. Our groundbreaking approach has the potential to transform treatment for conditions like chronic respiratory disorders, gut inflammation, immune deficiencies, and more, positioning us at the forefront of immunotherapy innovation.